| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |